The 20 Best Polymorphous Low Grade Adenocarcinoma Doctors in The United States

My practice focuses on the treatment of cancer with radiation therapy. I treat cancers of all sites including brain, breast, lung, head and neck, GI organs, prostate, GYN organs, and bone/soft tissue. We use multiple modalities of treatment including IMRT, SBRT, Stereotactic radiosurgery, and brachytherapy.Dr. Spencer Ashton is a radiation oncologist at Intermountain Healthcare. He specializes in the treatment of all cancer types and is trained in multiple advanced radiation delivery techniques including intensity-modulated radiation therapy, stereotactic body radiation therapy, and high and low-dose rate brachytherapy. Dr. Ashton is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Pleuropulmonary Blastoma, Lung Cancer, and Familial Prostate Cancer. Dr. Ashton is board certified in American Board Of Radiology. Dr. Ashton is currently accepting new patients.

. Dr. Shipstone is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Adult Immune Thrombocytopenia, Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, and Thrombocytopenia. Dr. Shipstone is board certified in American Board Of Internal Medicine.

Sandeep Chunduri is a Hematologist and an Oncologist practicing medicine in Crystal Lake, Illinois. Dr. Chunduri is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Vaginal Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Chunduri is board certified in American Board Of Internal Medicine, Hematology.

Dr. Mehta is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. He enjoys working with patients and family members. There are a wide variety of treatment options available for nearly every patient, so it is important to spend as much time as is needed in order to weight the benefits and risks to any particular approach. He feels that it is important that communication is open and honest. The goals of treatment, whether it is going for cure or maximizing quality of life should be openly discussed and re-discussed as the need arises. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Mehta is board certified in American Board Of Radiology. Dr. Mehta is currently accepting new patients.

Dr. Kristen Riegert holds a Bachelor of Science in Biology from Pacific University in Forest Grove, OR, and a Doctor of Medicine from Oregon Health & Science University in Portland. She completed an internal medicine internship with Providence Portland Medical Center and a radiation and oncology residency with the University of Arizona in Tucson. In 2014, Dr. Riegert began working as a radiation oncologist at a Walla Walla, WA hospital. She spent the next two decades there. In 2024, she moved to Grand Junction, CO, and joined Intermountain Health.She enjoys hiking, camping, and exploring the outdoors with her sons when she is not at work. Dr. Riegert is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Angiosarcoma. Dr. Riegert is board certified in American Board Of Radiology. Dr. Riegert is currently accepting new patients.

Dr. Joseph Sniezek is the Medical Director of Head & Neck Endocrine Surgery for Swedish Health Services. Dr. Sniezek graduated from West Point in 1990 and the Vanderbilt University School of Medicine in 1994. After completing an Otolaryngology residency in 1999, he performed a two-year fellowship at Vanderbilt in head and neck oncologic and reconstructive surgery. He has served as a department chief, residency program director, and subsequently as the Consultant to the Surgeon General of the Army for Otolaryngology/Head & Neck Surgery. His clinical practice focuses on the treatment of head and neck masses and tumors, with a particular interest in thyroid and parathyroid disease. In 2015, he was elected Teacher of the Year by the Swedish General Surgery Residency. He completed a Masters in Business Administration at the University of Washington in 2016. Dr. Sniezek has also been perennially recognized with Seattle Met and Seattle Magazine's Top Doctor award. Dr. Sniezek is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Parathyroid Adenoma, Parathyroid Cancer, Thyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Sniezek is board certified in American Board Of Otolaryngology - Head And Neck Surgery. Dr. Sniezek is currently accepting new patients.

General radiation oncology. Dr. Whipple is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma. Dr. Whipple is board certified in American Board Of Radiology. Dr. Whipple is currently accepting new patients.

. Dr. Redd is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Infant Hearing Loss, DFNB1, Jones Syndrome, and Meniere Disease.

. Dr. Zajonc is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Nasal Septal Hematoma, Low Nasal Bridge, Perichondritis, and Myringotomy. Dr. Zajonc is board certified in American Board Of Otolaryngology.

. Dr. Abkes is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Familial Isolated Hyperparathyroidism, Osteitis Fibrosa, and Neonatal Severe Hyperparathyroidism. Dr. Abkes is board certified in American Board Of Otolaryngology.

Jochen Lorch is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 32 years. Dr. Lorch is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Anaplastic Thyroid Cancer, Thyroid Cancer, Medullary Thyroid Carcinoma, Adenoid Cystic Carcinoma, and Thyroidectomy. Dr. Lorch is board certified in American Board Of Internal Medicine - Medical Oncology (Certified).

Nicholas Paul Campbell, MD, an oncologist at Endeavor Health, focuses on the treatment of lung cancer and cancers of the head and neck. With 16 years of experience, he cares for patients facing complex diagnoses such as esophagus, oropharyngeal and laryngeal cancers. Dr. Campbell develops individualized treatment plans tailored to each patient’s condition, including those with rare malignancies like Merkel cell carcinoma and basal cell cancer. Dr. Campbell is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. Dr. Campbell is board certified in American Board Of Internal Medicine.

Erik Cohen, MD, FACS Erik Cohen, MD is the Medical Director of Head and Neck Oncologic Surgery at Morristown Medical Center and is also Clinical Director of the Leonard B Khan Head and neck Cancer Institute at Morristown Medical Center's Carol G. Simon Cancer Center. He is trained in Otolaryngology-Head and Neck Surgery (ear, nose, and throat surgery) and fellowship trained in Head and Neck Oncologic Surgery.Dr. Cohen manages patients with benign and malignant head neck tumors of the head and neck. This includes cancers of the mouth, throat, larynx and HPV-associated oropharynx cancer. He also specializes in management of benign and malignant tumors of the thyroid and parathyroid glands, salivary gland surgery including parotidectomy with facial nerve preservation, nasal cavity and paranasal sinus tumors, complex skin cancer surgery, and skull base surgery. He is experienced in minimally invasive approaches, including transoral robotic surgery (TORS) as well as endoscopic CO2 laser surgery.Dr. Cohen attended Medical School at the Albert Einstein College of Medicine in New York. He completed his residency training in Otolaryngology-Head and Neck Surgery at Temple University Hospital in Philadelphia, and a fellowship in Head and Neck Oncologic Surgery at Memorial Sloan Kettering Cancer Center in New York City. He was a faculty member at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School prior to joining Morristown Medical Center and the Atlantic Health System in 2012. He is a past president of the New York Head and Neck Society and an active member of several professional societies. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Acinic Cell Carcinoma of Salivary Glands, Salivary Gland Tumors, Laryngeal Cancer, Thyroidectomy, and Gastrostomy. Dr. Cohen is board certified in American Board Of Otolaryngology - Head And Neck Surgery. Dr. Cohen is currently accepting new patients.

Matthew E. Spector, MD, FACS, completed his medical school training at Stritch School of Medicine, Loyola University in Chicago. He then went on to the University of Michigan where he completed his residency in Otolaryngology – Head and Neck Surgery and fellowship in Head and Neck Surgical Oncology and Microvascular Reconstruction. He was on faculty at the University of Michigan for 10 years where he served as the Director of the Head and Neck Oncology Program and Associate Director of the Head and Neck Surgical Oncology and Microvascular Reconstruction Fellowship. Dr. Spector is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Tongue Cancer, Laryngectomy, and Glossectomy. Dr. Spector is board certified in American Board Of Otolaryngology - Head And Neck Surgery. Dr. Spector is currently accepting new patients.

Nabil Saba is an Oncologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 36 years. Dr. Saba is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Throat Cancer, Glossectomy, and Tissue Biopsy. Dr. Saba is board certified in American Board Of Internal Medicine, 1997.

Dr. Bhuvanesh Singh, a board-certified otolaryngologist and physician scientist with a distinction in research, specializes in head and neck surgery and reconstruction with a particular expertise in skin cancers. He joins Northwell after 27 years at Memorial Sloan-Kettering Cancer Center, where he served as the director of Laboratory of Epithelial Cancer Biology and founder and co-director of the Advanced Skin Cancer Management and Prevention Program. A recognized leader in his field, Dr. Singh has served on the AJCC staging and NCCN guideline committees. He has published over 300 peer-reviewed manuscripts, 30 book chapters, and several textbooks, including one of the leading textbooks in head and neck oncology. He has delivered over 500 lectures worldwide. Additionally, as an NIH-funded researcher, he developed a novel antineoplastic compound that is currently being codeveloped with a pharmaceutical company for human use.Dr. Singh has performed over 10,000 surgical procedures, the experience from which has allowed him to develop innovative surgical approaches that have significantly enhanced outcomes for the many common head and neck oncological and reconstructive procedures such as thyroidectomy, neck dissection, and oral cavity and scalp reconstruction. His combined expertise in cancer ablation and facial cosmetic and reconstructive surgery enables him to optimize cancer treatment while achieving excellent cosmetic and functional results for his patients. Dr. Singh values the doctor-patient relationship, treating every patient as he would a family member. He has developed evidence-based strategies to enhance this relationship, emphasizing effective communication and care among all team members. By prioritizing holistic care and collaborative approaches, Dr. Singh aims to ensure that each patient feels valued and supported throughout their treatment journey. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Tissue Biopsy, and Thyroidectomy. Dr. Singh is board certified in American Board Of Otolaryngology.

Head and neck surgeon David Eisele specializes in surgery for malignant and benign tumors of the head and neck, with a focus on salivary gland neoplasms and disorders of the salivary glands that can be treated surgically. He is an expert in minimally invasive surgical approaches, including sialendoscopy. Salivary gland neoplasms and disorders are also the focus of Dr. Eisele’s research. He has published more than 300 research papers and edited multiple books related to head and neck surgery. Dr. Eisele earned a medical degree from Cornell University Medical College and completed residency training in general surgery and in otolaryngology–head and neck surgery at the University of Washington. From 2012 to 2025, he served as director of the Department of Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine. Dr. Eisele is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Salivary Duct Stones, Salivary Gland Tumors, Throat Cancer, Laryngectomy, and Gastrostomy. Dr. Eisele is board certified in Head And Neck Surgery.

My career began at Beth Israel Medical Center/Continuum Health Partners in Manhattan, as a Physician-Scientist at that institution s newly established Institute for Head and Neck and Thyroid Cancer. I developed a basic science research laboratory, collaborating with senior investigators at the NYU School of Dental Medicine. My research was funded through a combination of national society and private foundation career development awards, and resulted in several publications, nationally recognized basic science research in head and neck oncology, and several national presentations and awards. In 2007, I was hired as Chief of the Division of Head and Neck Surgery at Long Island Jewish Medical Center (LIJ), in the early years of the (then) North Shore-LIJ Health System and North Shore-LIJ Cancer Institute. In this role I helped to establish one of the first fully integrated multidisciplinary oncology programs in our growing health system dedicated to the initial evaluation, care and survivorship of cancer patients, specifically those with head and neck tumors. The Head and Neck Oncology Program at Northwell has now evolved into one of regional as well as national renown, with the ability to deliver sophisticated multidisciplinary surgical and nonsurgical head and neck oncologic care at multiple sites throughout our network. Our clinical team also maintains a close collaboration with leading senior basic science investigators at Northwell's Feinstein Institute, focusing on HPV-associated oropharynx cancer. In 2014, I was appointed Northwell Health Cancer Institute s first Director of Surgical Oncology, and served in this position until early 2019. In the Spring of 2019, I was appointed Director of Operations of the Northwell Health Cancer Institute. In this capacity I serve as the liaison between the Institute, its members, and the various hospitals and outpatient cancer treatment facilities throughout the Northwell network where cancer care is delivered. In 2015, I was appointed Chair of LIJ s Commission on Cancer (CoC) recognized Cancer Committee. In this role I have worked with clinical and administrative colleagues to better integrate the inpatient cancer activities and resources of LIJ and North Shore University Hospital with those of our outpatient Cancer Institute facilities. I am presently involved in defining and solidifying Cancer Institute oversight over inpatient cancer related resources and activities, as well as CoC standards. My clinical leadership and program building accomplishments have been recognized both regionally as well as nationally with an American Cancer Society Doctor of Distinction Award (2017), an American Head and Neck Society Presidential Citation (2017), and a position on the Advanced Training Council of the American Head and Neck Society. Dr. Frank is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Glossectomy. Dr. Frank is board certified in American Board Of Otolaryngology.

Guy Petruzzelli is an Otolaryngologist practicing medicine in Peoria, Illinois. Dr. Petruzzelli is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Tracheal Rupture, Hyperparathyroidism, Tongue Cancer, Laryngectomy, and Gastrostomy. Dr. Petruzzelli is board certified in American Board Of Otolaryngology - Head And Neck Surgery.

. Dr. Coen is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Posterior Fossa Tumor. Dr. Coen is board certified in American Board Of Radiology.